78.7%
Chimeric antigen receptor (CAR) T cell therapysolid tumorsDNMTihematological cancerDNMTi-exposedDNMTis
…Background Chimeric antigen receptor (CAR) T cell therapy has revolutionized hematological cancer treatment but faces sig…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,321–1,380 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
endovascular catheter rewarming1fibrinolytics1host directed treatments1iTBS1immuno-chemotherapy1inhaled aminoglycosides1insulin regimen1keratoplasty1language therapy1neuropsychology testing1pTVE1percutaneous transluminal angioplasty with stenting1poRT1post-acute stroke rehabilitation1prophylactic compression hosiery1repetitive peripheral magnetic stimulation1respiratory specialist review1secondary prevention medication regimens1sinonasal surgery1spirometry1tenodesis1therapeutic vaccination1Angiogenic therapy1Anti-H.pylori treatment1Antiresorptive or anabolic therapy1Autologous serum eye drops1B cell therapy1BACE1BGM1BiTE therapy1Biological treatments1Bronchial Thermoplasty1C-ion RT1CAH1CBCT-NB1CD19-targeting CAR T cell therapy1CIO1CKM1CNI therapy1Capsule sponge1Collagen supplementation1Complete endovascular sinus occlusion1D2N1DAPTs1Direct percutaneous embolisation1Double lung transplantation1EAE1EBAC1ECMO1ELPS1EPC1ERAI1ESG1ESP-block1EV–Pem1EXER+RPW1EmOC1Endoscopic neurotomy1FB DOTS1FS-LASIK1
Articles mentioning treatments
7,227 articles · page 495 of 603Autologous CAR-T cell therapieshematologic malignanciesIITautoimmune diseasesAID
…Background Autologous CAR-T cell therapies have demonstrated remarkable efficacy in hematologic malignanci…
BCMA-targeting CAR-T cell therapymultiple myelomaLTG3551cilta-celNew England Journal of Medicineciltacabtagene autoleucelIde-celMMidecabtagene vicleucel
…pokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature medicine. 2021 Dec;27(12):2099-103.Gust J. BCMA-CAR T-c…
Chimeric Antigen Receptor T (CAR-T) cell therapysolid tumourshaematological malignanciesEuropean Research CouncilERCanticancer drugsMinisterio de Educacion y Formacion ProfesionalHorizon 2020 research and innovation programmesolid tumorsICoMICS
…Background Chimeric Antigen Receptor T (CAR-T) cell therapy has demonstrated remarkable success in treating haematological …
75.5%
Chimeric Antigen Receptor T (CAR T) cell therapiesAB-3028mCRPCsolid tumorsTCGAhematological malignanciesmetastatic castration-resistant prostate cancer (mCRPC)The Cancer Genome Atlasprostate tumorsGTEx
…Background Chimeric Antigen Receptor T (CAR T) cell therapies have achieved curative outcomes in some hematological malignanc…
chimeric antigen receptor T cell (CAR-T) therapyglioblastoma multiformeGBM
… is a potential strategy for enhancing immunotherapies, such as chimeric antigen receptor T cell (CAR-T) therapy, providing a promising avenue for treating aggressive tumors su…
CAR-T cell therapysolid tumorshematological malignanciesAC484ABBV-CLS-484
…Background Adoptive cellular therapy (ACT) in the form of CAR-T cell therapy has demonstrated potent clinical efficacy in hematological mali…
CAR-T cell therapiesAcute myeloid leukemiaChampions OncologyGM-CSFTaconic BiosciencesAMLIL-3
…ncluding monoclonal antibodies, bispecific T-cell engagers, and CAR-T cell therapies—in a system that preserves both human immune functionality and …
T Cell Receptor (TCR)-Based cellular therapyipilimumabnivolumabFibrolamellar carcinoma (FLC)DNAJ-PKAcJohns Hopkins IRB
…all goal is to target this ‘undruggable’ oncogenic driver using T Cell Receptor (TCR)-Based cellular therapy.Methods We are performing a clinical trial of a peptide-based t…
adoptive cell therapysolid tumorsRoswell Park Comprehensive Cancer Centerovarian cancerRPCCC
…of IVS generating polyclonal cytotoxic T lymphocytes (CTLs) for adoptive cell therapy against highly heterogenous solid tumors remain to be establish…
Trastuzumab-based treatmentsTrastuzumab deruxtecantrastuzumab-deruxtecanHER2-low breast cancerHER2-low tumorstrastuzumabhuman breast cancermetastatic breast cancerU of North Texas
…xpressing tumors, do not depend on HER2 signaling for survival. Trastuzumab-based treatments have failed to improve the outcomes of patients with HER2-low b…
cancer immunotherapy
… across diverse tumor types and represent promising targets for cancer immunotherapy. Clinical trials targeting these neoantigens have shown encoura…